Table 2.

Details on chemotherapy regimens used concurrently with radiation therapy

	CR on PET/CT	<CR on PET/CT
Cisplatin based
Cisplatin alone	169 (92%)	14 (8%)
Cisplatin + bevacizumab	35(97%)	1 (3%)
Cisplatin + paclitaxel	3 (100%)	0 (0%)
Carboplatin based
Carboplatin + 5-FU	26 (90%)	3 (10%)
Carboplatin + paclitaxel	8 (80%)	2 (20%)
Cetuximab based
Cetuximab alone	30 (83%)	6 (17%)
Cetuximab + paclitaxel	3 (75%)	1 (25%)
Cetuximab + paclitaxel-NAB	2 (100%)	0 (0%)

CR = complete response; <CR = incomplete response; CT = computed tomography; PET = positron emission tomography.